THE ROLE OF NEUROHORMONAL FACTORS IN THE FORMATION OF A PATIENT'S CLINICAL PROFILE AND THE IMPACT ON STRUCTURAL

Mariana O Vatseba1, Nadiia M Haliuk1, Tetiana V Merhel1

  • 1IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|November 10, 2023
PubMed

Insights

Galectin-3 levels increase with heart failure after myocardial infarction, correlating with cardiac remodeling. This suggests galectin-3 can help diagnose and predict outcomes in these patients.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Myocardial infarction (MI) can lead to chronic heart failure (CHF).
  • Cardiac and vascular remodeling are key pathological processes following MI.
  • Galectin-3 is a protein implicated in inflammatory and fibrotic processes.

Purpose of the Study:

  • To investigate the role of galectin-3 in the clinical profile of patients with MI.
  • To assess the impact of galectin-3 on cardiac and vascular remodeling post-MI with reperfusion therapy.

Main Methods:

  • Studied 140 patients with CHF post-MI (FC II-III) and 22 patients with MI without CHF.
  • Analyzed serum galectin-3 concentrations.
  • Correlated galectin-3 levels with left ventricular remodeling indicators (ESV, LVEDV).

Main Results:

  • Elevated serum galectin-3 in MI patients with CHF (35.2-38.94 ng/ml) compared to healthy subjects (6.57 ng/ml).
  • Significantly higher galectin-3 in patients with stenting without CHF (10.87 ng/ml) vs. healthy.
  • Positive correlations found between galectin-3 and left ventricular volumes (ESV, LVEDV).

Conclusions:

  • Galectin-3 concentration correlates with left ventricular remodeling in post-MI CHF.
  • Galectin-3 serves as a potential marker for early diagnosis, prognosis, and risk stratification in post-MI remodeling.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
675
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.3K